Delivery Order SPE2DX22D0099-SPE2D826FAD1C

The U.S. Defense Logistics Agency Medical Supply Chain awarded a $32,048.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major pharmaceutical distributor serving federal medical procurement needs.

AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to deliver diverse medical products through competitive federal procurement, combined with its role as a prime vendor under the DLA Pharmaceutical Prime Vendor Global Program, positions it as a critical supplier for Defense Health Agency and other government healthcare systems. This delivery order exemplifies the company's ongoing role in fulfilling federal medical supply requirements through flexible contract vehicles that enable rapid response to military healthcare needs.